Effect of patient and tumor characteristics on respiratory motion in early-stage peripheral lung cancer (Tis ~ T2bN0M0) treated with stereotactic body radiation therapy (SBRT).

BACKGROUND

Recent advances in stereotactic body radiation therapy (SBRT) technology for early-stage peripheral lung cancer have been remarkable and are becoming a viable alternative to surgery. However, the most important problem in performing SBRT correctly is minimizing the respiratory motion of the tumor.

MATERIALS AND METHODS

Thirty-eight patients treated with SBRT were evaluated to clarify factors affecting respiratory motion of early-stage peripheral lung cancer in the management of restrictive breathing technique (abdominal compression) to reduce respiratory tumor motion in SBRT. We investigated age, gender, body mass index (BMI), Brinkman index (BI), forced expiratory volume in 1 second (FEV 1.0), and type of ventilatory impairment as patient factors, and T-factor, stage, tumor-bearing lung lobe, and tumor pathology as tumor factors. Respiratory motion was assessed by volume differences between clinical target volume (CTV) and internal target volume (ITV). The degree of tumor motion due to respiration was compared using the formula of (ITV-CTV)/CTV as an index.

RESULTS

In the results, univariate analyses showed that only age was a significant predictor of respiratory tumor motion (p = 0.048). In multi-variate analyses, only T factor was an independent significant predictor of respiratory tumor motion (p = 0.045), while there was a significant trend for age (p = 0.061), and tumor location (p = 0.067).

CONCLUSIONS

In late elderly patients or T1a tumor, respiratory motion in early-stage peripheral lung cancer was significantly large. However, it is not predictable by patient and tumor characteristics. Therefore, respiratory motion of the tumor should be measured in all patients in some way.